Watertown, Massachusetts
United States
22
2015-03-05
14
2017-07-18
These are the the leading inventors for applications assigned to Dicerna Pharmaceuticals, Inc.:
Dicerna Pharmaceuticals, Inc. based in Watertown, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Methods and compositions for the specific inhibition of MCL1 by double-stranded RNA
#2 | 2014-12-18 ✅ Patent 9,549,983 granted on 2017-01-24Amine cationic lipids and uses thereof
#3 | 2014-10-23 ✅ Patent 9,670,488 granted on 2017-06-06Methods and compositions for the specific inhibition of met by double stranded RNA
#4 | 2014-08-07Extended Dicer Substrate Agents and Methods for the Specific Inhibition of Gene Expression
#5 | 2014-06-26 ✅ Patent 9,217,146 granted on 2015-12-22Phase changing formulations of nucleic acid payloads
#6 | 2014-06-05METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITIONS OF EGFR BY DOUBLE-STRANDED RNA
#7 | 2014-04-17 ✅ Patent 9,365,850 granted on 2016-06-14Methods and compositions for the specific inhibition of MYC by double-stranded RNA
#8 | 2014-02-13 ✅ Patent 9,913,907 granted on 2018-03-13RNAi pharmaceutical composition for suppressing expression of KRAS gene
#9 | 2013-08-29 ✅ Patent 9,320,798 granted on 2016-04-26Lipid delivery formulations
#10 | 2013-05-23 ✅ Patent 8,927,515 granted on 2015-01-06Methods and compositions for the specific inhibition of androgen receptor by double-stranded RNA
#11 | 2013-05-16 ✅ Patent 9,200,284 granted on 2015-12-01Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
#12 | 2013-05-02 ✅ Patent 8,815,825 granted on 2014-08-26Methods and compositions for the specific inhibition of beta-catenin by double-stranded RNA
#13 | 2013-04-18 ✅ Patent 8,927,705 granted on 2015-01-06Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
#14 | 2012-10-18MULTIPLEX DICER SUBSTRATE RNA INTERFERENCE MOLECULES HAVING JOINING SEQUENCES
#15 | 2012-04-19COMPOSITIONS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY NUCLEIC ACID CONTAINING A DICER SUBSTRATE AND A RECEPTOR BINDING REGION
#16 | 2011-05-12PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION
#17 | 2011-03-10PEPTIDE DICER SUBSTRATE AGENTS AND METHODS FOR THEIR SPECIFIC INHIBITION OF GENE EXPRESSION
#18 | 2011-01-27 ✅ Patent 8,372,816 granted on 2013-02-12Methods and compositions for the specific inhibition of KRAS by asymmetric double-stranded RNA
#19 | 2011-01-06 ✅ Patent 8,349,809 granted on 2013-01-08Single stranded extended dicer substrate agents and methods for the specific inhibition of gene expression
#20 | 2010-07-22EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
#21 | 2010-07-08 ✅ Patent 8,513,207 granted on 2013-08-20Extended dicer substrate agents and methods for the specific inhibition of gene expression
#22 | 2010-07-08EXTENDED DICER SUBSTRATE AGENTS AND METHODS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION
Also check out Dicerna Pharmaceuticals, Inc.'s (Watertown, United States) applicant profile with 15 patent applications submitted.
18654 ⎘